Cleared Traditional

K901104 - PARAMAX ASPARTATE AMINOTRANSFERASE REAGENT

K901104 is the FDA 510(k) clearance for PARAMAX ASPARTATE AMINOTRANSFERASE REAGENT by Baxter Healthcare Corp. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K901104 · Baxter Healthcare Corp · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1990
Decision
15d
Days
Class 2
Risk

K901104 is an FDA 510(k) clearance for the PARAMAX ASPARTATE AMINOTRANSFERASE REAGENT. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Santa Ana, US). The FDA issued a Cleared decision on March 23, 1990 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

Submission Details

510(k) Number K901104 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 1990
Decision Date March 23, 1990
Days to Decision 15 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 88d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 107
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K901104.
COULTER DART AST (GOT) REAGENT
K905771 · Coulter Electronics, Inc. · Feb 1991
AST REAGENT
K903829 · Amresco, Inc. · Sep 1990
ASPARTATE AMINOTRANSFERASE TEST
K903197 · Em Diagnostic Systems, Inc. · Aug 1990
COULTER AST (GOT) REAGENT
K897165 · Coulter Electronics, Inc. · Feb 1990
COBAS READY CARDIO PROFILE REAGENT STRIP
K896228 · Roche Diagnostic Systems, Inc. · Feb 1990
COBAS READY PROFILE 1 REAGENT STRIP
K896229 · Roche Diagnostic Systems, Inc. · Feb 1990